Financing, Equity Capital Markets

IGM Biosciences, Inc.

09/19
|
$201.3 Million
Piper Sandler served as bookrunner for IGM Biosciences, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma